March 7, 2023
Latest News
Press Releases
March 2, 2023
IAVI and BARDA expand partnership to advance IAVI’s filovirus vaccine candidates
December 2, 2022Scientists reveal encouraging findings in first-in-human clinical trial evaluating HIV vaccine approach
October 25, 2022IAVI to accelerate promising investigational Sudan ebolavirus vaccine development for potential outbreak research and response
August 31, 2022IAVI announces first vaccinations at Liberia site in Phase I clinical trial of Lassa fever vaccine candidate
August 29, 2022Japan reiterates commitment to HIV vaccine development with a $10.5 million contribution to IAVI
Features
March 9, 2023
IAVI kicks off second cohort of Leadership Development Program
March 7, 2023Why we need women leaders in science and research
March 6, 2023New tuberculosis vaccines needed to tackle antimicrobial resistance
February 22, 2023The Netherlands renews their support to IAVI for the development of new HIV prevention technologies
February 7, 2023New IAVI-authored paper proposes additional regulatory pathways for filovirus vaccines
Media Contacts
North America
Rose Catlos
+1 212 847 1049
RCatlos@iavi.org
